Lymphoma Tx Linked to Mild Photodistributed Skin Reactions
About 1 in 5 patients with B-cell lymphoma treated with loncastuximab develop skin-related adverse events, particularly photodistributed erythematous patches, a study finds.
Medscape Medical News
source https://www.medscape.com/viewarticle/lymphoma-treatment-linked-mild-photodistributed-skin-2026a100065u?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/lymphoma-treatment-linked-mild-photodistributed-skin-2026a100065u?src=rss
Comments
Post a Comment